Different doses (1.14 g/kg, 2.27 g/kg and 4.54 g/kg) of PC–AR were orally administered to the rats once per day for four weeks to determine the therapeutic effect of PC–AR on HFD-induced HLP. The gene discussed is AR; the disease is hyperkeratosis lenticularis perstans.